Table 3.
Number of test‐positive and test‐negative patients according to tumour regression grade for response assessment on T2‐weighted combined with diffusion‐weighted MRI
| Mandard grade | No. of patients | |||||
|---|---|---|---|---|---|---|
| Reader 1 | Reader 2 | Reader 3 | ||||
| MRI‐positive | MRI‐negative | MRI‐positive | MRI‐negative | MRI‐positive | MRI‐negative | |
| TRG 1 | 6 | 6 | 7 | 5 | 7 | 5 |
| TRG 2 | 16 | 1 | 16 | 1 | 15 | 2 |
| TRG 3 | 15 | 1 | 16 | 0 | 14 | 2 |
| TRG 4 | 4 | 0 | 4 | 0 | 4 | 0 |
| TRG 5 | 2 | 0 | 2 | 0 | 2 | 0 |
TRG, tumour regression grade according to Mandard and colleagues3; MRI‐positive, clinical residual tumour; MRI‐negative, clinical complete response.